Found Review: the one GLP-1 program with published results and an insurance card
Found is the standout in this category and it is not close. It is the only major GLP-1 telehealth program with a peer-reviewed, published outcome study behind it — 66,094 patients — the only one that bills your insurance for the medication, and the only one that will hand you FDA-approved branded Wegovy or Zepbound instead of a compounded substitute. If your plan covers GLP-1s, this is the easiest recommendation on this site.
- It is the only one that has actually published its results. A peer-reviewed study in Obesity Science & Practice covering 66,094 patients found GLP-1 users averaged 13.9% of body weight lost at twelve months, with 82.9% maintaining their loss over the year and nearly half dropping a full BMI category. No competitor on this site has published anything comparable — most have published nothing at all.
- Insurance is the killer feature. Found is in-network with Aetna, Anthem BCBS, Cigna, UnitedHealthcare and several regional plans, covering 100M+ lives, and navigates coverage in all 50 states. Members with coverage commonly report copays around $30 — for the branded drug.
- The widest formulary in the category, by a distance. Branded Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda, Victoza, Trulicity and Rybelsus, plus compounded semaglutide and tirzepatide and non-GLP-1 options like metformin, topiramate, Contrave and bupropion/naltrexone — 13 medications in 60+ combinations. If the first thing does not work, there is a second thing.
- Cash pricing starts at $99/month and stays there as your dose escalates, which is where most competing plans quietly get more expensive around month six.
- People genuinely like using it — 4.7 out of 5 from about 8,700 App Store ratings, the best app score of any program we cover, plus a BBB A+ with accreditation and replies to 92% of its negative Trustpilot reviews.
- Check before you commit: the membership fee is separate from the medication and is not billable to insurance, Found publishes several different price structures across its own site, and a cancellation fee can apply mid-term. Read the final checkout screen — that is the number that counts.
What third-party reviewers say
Found holds 3.5 out of 5 on Trustpilot from 663 reviews. Separately it holds 4.7 out of 5 from about 8,700 ratings on the Apple App Store and 4.5 from roughly 1,570 reviews on Google Play, where the app has passed 50,000 downloads. The Better Business Bureau lists Found as accredited since 29 April 2024 with an A+ rating, alongside 89 complaints closed in three years, 54 of them in the last twelve months.
Billing and charges
The most common negative theme across this whole category, and Found is not exempt: unexpected renewal charges and confusion over what the membership fee does and does not include.
Found answers back
Found responds to about 92% of its negative reviews — unusually high. Public replies are not the same as resolution, but they do mean complaints are being read.
The clinical side reviews well
Positive reviews concentrate on clinician access, the app and the coaching content, which lines up with the 4.7 App Store score.
Pricing: cheap if you have insurance, and flat if you do not
Start with the good news, because it is genuinely good. If your plan covers GLP-1s, Found bills it and members commonly report copays around $30 — on branded, FDA-approved medication. That is a price no cash-pay compounded program on this site can touch, on a product none of them can supply. And if you are paying cash, Found’s compounded plans start at $99/month and hold that price as your dose climbs, which is where a lot of cheaper-looking competitors overtake it around month six.
Now the part to actually check. Found publishes several different price structures across its own website at the same time — none hidden, none expired, just sitting on different pages. Which one you land on depends on your state, your plan and the page you entered through. Here they are, so you can recognise yours:
| Where it appears | What it says |
|---|---|
| Main plans page | $99/mo with insurance and $169/mo cash — both requiring 12 months paid up front. Month-to-month equivalents are $199 and $289. Compounded medication included. |
| CORE / PLUS page | CORE self-pay $129 per 30 days, or 2 × $348 quarterly, or $594 for six months then $129/mo. PLUS self-pay $199 per 30 days. PLUS with insurance $39/mo or $199/yr. On this page GLP-1s and Contrave are excluded from the fee. |
| Insurance page | “Memberships starting at $17/month” and “copays as low as $0.” |
| Kickstart promotion | First month free at $129, then $74.99/mo. Compounded semaglutide renews at $189/month. |
For branded medication paid in cash, Found’s own materials cite roughly $1,100/month for Ozempic and Mounjaro and “from $650/month” for Wegovy and Zepbound. A Found press release dated 14 May 2025 quoted materially lower figures — $499/month for Wegovy and $349–$699 for Zepbound vials. We could not establish which set is current, so we are reporting both rather than picking one.
How the insurance billing actually works
Found is in-network with Aetna, Anthem Blue Cross Blue Shield, Cigna and UnitedHealthcare plus a number of regional plans, and it announced in October 2024 that this reached more than 100 million covered lives. Where coverage applies, members typically report a copay around $30 for the medication itself.
Two caveats that matter more than the headline:
What insurance does cover
- The GLP-1 prescription itself, where your plan covers GLP-1s for weight management and you meet its criteria.
- Copays as low as around $30 in the plans we could find member reports for.
- Branded product — this is the only program on this site where branded Wegovy or Zepbound is realistically affordable.
What it does not cover
- The Found membership fee. Found states this directly: the subscription fee is not covered by insurance.
- California. At the time of checking, Found’s insurance flow showed no plans available in California.
- Lab work, where required. We could not establish a published lab cost.
- Plans that exclude weight-management drugs entirely — which is a large share of employer plans.
What you can actually be prescribed
Found advertises “15+ medications,” which is broader than the compounded-only programs. In practice that breaks into three groups: branded GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda, Victoza, Trulicity, Rybelsus); compounded semaglutide and tirzepatide, dispensed through 503A pharmacies only; and non-GLP-1 options including metformin, topiramate, zonisamide, Contrave, bupropion and naltrexone.
Found also markets Foundayo™, an oral GLP-1. It is worth being precise about what that is: Foundayo is Eli Lilly’s orforglipron, the first oral GLP-1 approved by the FDA for weight loss, cleared on 1 April 2026. It is a branded, FDA-approved product — not something Found formulates. Lilly lists it from $149/month self-pay, $25/month with a commercial savings card, and $50/month under Medicare Part D from 1 July 2026. We could not verify that Found is actually dispensing it yet, so treat its appearance in Found’s marketing as an offer to check, not a confirmed inventory item.
On the compounded side, Found’s own disclosure is unusually direct, and we will quote it because it is the correct framing: “Compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy, and not available in all states.”
Refunds, cancellation and the fine print
Found offers a full refund only within three days of purchase, or before your first clinician consultation, or if you are medically disqualified. After that, renewals, dispensed medication and lab kits are non-refundable.
Who is behind Found
Found has raised roughly $132 million and has been led by CEO Luca Ranaldi since July 2024. It claimed more than 250,000 patients as of October 2024. Found is not itself a medical provider — care is delivered by contracted practices, specifically Pippen Health and Cloud Health Medical Group. That structure is normal in telehealth but it does mean your clinician relationship is with the practice, not with Found.
Found has published an outcomes study in Obesity Science & Practice (January 2025, n = 66,094) reporting roughly 10% mean weight loss at twelve months — 13.9% among GLP-1 users versus 8% among non-GLP-1 users. It is peer-reviewed, which is more than any competitor on this site offers, but the authors are Found-affiliated and the data is Found’s own. Read it as a strong company-generated signal rather than as independent evidence.
Regulatory record: we found no FTC action, no class action and no lawsuit against Found. One point of confusion worth clearing up — the FTC’s enforcement action against NextMed, which reached a final order in December 2025, involves a different company entirely and has nothing to do with Found.
Check whether your insurance is in-network with Found →Who Found is right for
Sign up if
- You have commercial insurance through Aetna, Anthem BCBS, Cigna or UnitedHealthcare and want branded Wegovy or Zepbound rather than a compounded copy.
- You want a clinician who can also prescribe non-GLP-1 options if a GLP-1 is not right for you.
- You want an app and structured coaching alongside the prescription.
- You would rather deal with a company that actually answers its critics in public.
Look elsewhere if
- You are paying cash and want the single lowest number on the market — bmiMD verified lower, though without the branded formulary or the published outcome data.
- You are in California, where the insurance flow showed no available plans when we checked.
- You want to know your exact monthly cost before you reach the checkout screen, rather than at it.
- You want one flat all-in number with no membership fee sitting alongside the medication cost.
Frequently asked questions
Does Found take insurance?
Yes, for the medication. Found is in-network with Aetna, Anthem BCBS, Cigna, UnitedHealthcare and several regional plans, and members with coverage commonly report copays around $30. Found's own membership fee is not covered by insurance — you pay that separately.
How much does Found cost?
That depends on which Found page you sign up through. Found publishes at least four different structures: $99/mo with insurance or $169/mo cash on 12-month prepaid terms; CORE at $129 per 30 days and PLUS at $199; "memberships starting at $17/month" on the insurance page; and a Kickstart promotion at $129 for the first month then $74.99/mo. Confirm the price at checkout before paying.
Is Found legitimate?
Yes, and it has the strongest paper trail of any program we cover. Found is BBB-accredited with an A+ rating, has raised about $132 million from investors including WestCap, IVP and GV, claims more than 250,000 patients, and is the only program on this site to have published a peer-reviewed outcomes study. We found no FTC action, class action or lawsuit against it. Its Trustpilot score of 3.5 reflects billing friction rather than any question about whether the service works.
Does Found actually work?
It is the only program on this site that has published evidence either way. A peer-reviewed study of 66,094 Found patients in Obesity Science & Practice reported roughly 10% mean weight loss at twelve months across the whole cohort and 13.9% among GLP-1 users, with 82.9% maintaining their loss over the year. The study is Found-authored on Found's own data, so read it as a strong company-generated signal rather than as independent evidence — but no competitor has published anything to compare it against.
Can I cancel Found and get a refund?
A full refund is available only within three days of purchase, before your first consultation, or if you are medically disqualified. After that, renewals, dispensed medication and lab kits are non-refundable.
Does Found prescribe branded Wegovy and Zepbound, or compounded copies?
Both. Found's formulary includes branded Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda, Victoza, Trulicity and Rybelsus, as well as compounded semaglutide and tirzepatide through 503A pharmacies. Compounded products are not FDA-approved.
What is Foundayo?
Foundayo is Eli Lilly's orforglipron, the first oral GLP-1 approved by the FDA for weight loss, cleared on 1 April 2026. It is a branded FDA-approved drug, not a Found in-house product. We could not verify that Found is currently dispensing it.
Sources
- Trustpilot review page for joinfound.com (rating, review count, response rate).
- Better Business Bureau profile for Found (accreditation date, A+ rating, complaint counts).
- Apple App Store and Google Play listings for the Found app (Found Health, Inc.).
- joinfound.com — plans page, CORE/PLUS page, insurance page, Kickstart promotion page, and terms of service.
- Found press release, 14 May 2025 (branded medication pricing).
- Found announcement, 30 October 2024 (insurance network reach).
- Obesity Science & Practice, January 2025 — Found-authored outcomes study, n = 66,094.
- U.S. Food and Drug Administration approval of orforglipron (Foundayo), 1 April 2026.
- FDA proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B Bulks List, 30 April 2026.
Figures on this page were checked on 27 July 2026. Prices, promotions and third-party ratings change frequently — always confirm the current price on the provider’s own checkout before you pay.
Go to Found →